Guide 4: Medical Decision Making Decoded | PhysicianCodingGuide.com

Medical decision making (MDM) is how most office visits get coded under the current rules. You meet or exceed two out of three columns in the MDM table, and that determines your level of service. The table has four levels: straightforward, low, moderate, and high. Those levels correspond to the E/M code you can bill.

Definition: medical decision making

Medical decision making, or MDM, is the measure of the cognitive work a visit required: how many problems you addressed and how complex they were, how much data you reviewed and analyzed, and how much risk your decisions carried. Since 2021 it is one of the two ways to select an office visit level, the other being total time. It is not a count of how much you wrote.

The table looks complicated. In practice, for most clinical encounters, it is not. This chapter walks through each element clearly and shows you what to write in your note to document it. The goal is not to add work to your day, you are already doing the thinking the MDM table measures. The goal is to make sure your note shows it.

The Four MDM Levels and the Codes They Correspond To

MDM Level	New Patient CPT	Established Patient CPT	wRVUs (New / Est. Patient)
Straightforward	99202	99212	0.93 / 0.70
Low	99203	99213	1.60 / 1.30
Moderate	99204	99214	2.60 / 1.92
High	99205	99215	3.50 / 2.80

The Three Columns: What Each One Measures

The MDM table has three columns. You need to meet or exceed two of them to support a given level. Think of each column as asking a different question about your encounter.

Column 1: Number and Complexity of Problems Addressed

This column asks: how many problems did you address, and how complicated are they? The key word is addressed, meaning you actively evaluated, treated, or managed the problem during this encounter. Documenting a problem exists is not the same as addressing it.

Straightforward: One self-limited or minor problem (a cold, a minor laceration, a wart).
Low: Two or more self-limited problems, OR one stable chronic illness, OR one acute uncomplicated illness.
Moderate: One or more chronic illnesses with exacerbation, progression, or side effects of treatment; OR two or more stable chronic illnesses; OR one undiagnosed new problem with uncertain prognosis; OR one acute illness with systemic symptoms.
High: One or more chronic illnesses with severe exacerbation, progression, or side effects; OR one acute or chronic illness or injury that poses a threat to life or bodily function.

Practical tip: two stable chronic illnesses reach level 4

A stable chronic illness is a long-term condition (expected to last at least a year, or until death) that is at its treatment goal and not currently worsening: well-controlled hypertension, type 2 diabetes at target, stable hypothyroidism. Two of them, actively addressed at the same visit, meet moderate complexity on the problems column by themselves, which supports a level 4 (99214 established, 99204 new). You do not need an acute problem to get there. Contrast two situations to see why the column rewards complexity rather than effort: a patient seen only for a common cold is one self-limited problem, straightforward, a level 2; a patient whose type 2 diabetes is uncontrolled, requiring a change in therapy, is itself a moderate-to-high problem and on its own can support a level 4. What matters is the number and severity of the problems you genuinely addressed and documented, not how long the visit felt.

Column 2: Amount and Complexity of Data Reviewed and Analyzed

This column asks: what did you review in order to make your decision? It rewards providers who actively engage with data, not just order tests, but review results, interpret records, and coordinate with other providers.

Straightforward: Minimal or no data.
Low: Limited, order or review tests; review external records; use the independent interpretation of a test you personally ordered and reviewed.
Moderate: Moderate, review external records AND order or review tests OR obtain independent interpretation of results; OR have an independent discussion with an external physician about the patient's management.
High: Extensive, review external records AND independently interpret test results AND discuss with external physicians. Alternatively, this column can be met if you review and summarize old records with independent interpretation.

One point that surprises many providers: reviewing an X-ray or MRI that you personally ordered and interpreting it yourself (not just reading the radiologist's report) counts toward this column. If you look at the films and your note reflects your own independent interpretation, that is data analysis that belongs here.

Column 3: Risk of Complications or Morbidity from Treatment

This column asks: how risky is what you did or decided? This is often the easiest column to support when the others fall short, because the risk rubric captures clinical complexity that every clinician intuitively understands.

Minimal: OTC drugs, minor surgery with no identified risk factors.
Low: Prescription drug management, minor surgery with identified risk factors.
Moderate: Prescription drug management with monitoring for toxicity; elective major surgery with identified risk factors; diagnosis or treatment significantly limited by social determinants of health; decision regarding hospitalization; decision regarding minor surgery in a patient with identified risk factors.
High: Drug therapy requiring intensive monitoring for toxicity (anticoagulants, immunosuppressants); decision regarding emergency major surgery; decision not to resuscitate or to de-escalate care because of poor prognosis.

A note on prescription drugs

Any visit where you are managing or adjusting a prescription medication, even a straightforward one, meets the low threshold for risk. A visit where you are prescribing a medication that requires ongoing monitoring for toxicity (like methotrexate, warfarin, or lithium) meets the moderate threshold.

What "minor surgery" means in the risk column

The risk column refers to the procedure's global period, not how difficult it felt. A minor procedure with no identified risk factors (for example a simple skin tag removal or a single trigger-point injection, often a 0-day global) sits at low risk on its own. A procedure with a 10-day global, or any procedure in a patient with risk factors that complicate it, pushes the risk higher. The same logic scales up: a decision for major surgery, one carrying a 90-day global, is high risk. Document the procedure, its indication, and any factors that raise the patient's risk, and the column takes care of itself.

You Need Two of Three, Not All Three

The intimidating table, and the plain-language version

The official MDM table is a dense grid: four columns of qualifiers, sub-bullets for data subcategories, and risk language like "drug therapy requiring intensive monitoring for toxicity." Read cold, it is genuinely off-putting, and it is why many clinicians avoid the whole subject. Here is the plain-language version that captures almost every real visit. Ask three questions. How many problems did I deal with, and how sick is the patient? How much data did I dig into, labs, images, outside records, other clinicians? How risky was my plan, mainly meaning what I prescribed or decided? Score each as straightforward, low, moderate, or high, take the level that at least two of the three reach, and document those two clearly. You do not need to memorize the grid; you need to answer those three questions honestly in the note.

This is the rule providers most frequently misunderstand. You do not need to meet all three columns at a given level. You need to meet or exceed two of the three. This means that if your encounter has a very complex problem (column 1) and moderate-risk management (column 3), you can support a moderate-level visit even if your data review was minimal.

Conversely, if you had a straightforward problem but you reviewed extensive outside records and had a lengthy discussion with a consulting specialist, your column 2 strength may pull the overall level up.

What to Actually Write in Your Note

The MDM table is only useful if your note documents the elements it requires. Here is what to include for a moderate complexity visit (99214):

For column 1: name every problem you addressed and its status. "Managed hypertension and type 2 diabetes; both at goal on current therapy. Adjusted metformin dosing given recent weight change." That is two stable chronic illnesses, explicitly addressed, which is moderate complexity on this column.

For column 2: Name the data you reviewed. "Reviewed today's in-office HbA1c and basic metabolic panel. Reviewed outside cardiology note from three months ago." That is test review plus external records, moderate complexity for this column.

For column 3: reflect the risk in your management plan, and say enough to show which risk level applies. "Continuing metformin 1000 mg twice daily; will monitor renal function given mild chronic kidney disease and recheck a basic metabolic panel in three months." Routine prescription management like this is moderate risk, which supports level 4. It would rise to high risk only if the decision involved something markedly more dangerous, for example starting a medication that requires intensive toxicity monitoring, or weighing hospitalization. Naming the specific drug, the dose, and why you are monitoring is what makes the risk level visible to anyone reading the note.

That note, clearly written, supports a 99214, an established-patient level 4 visit, and it is not meaningfully longer than what most providers would write anyway. The difference is that it names the elements the coding system scores rather than leaving them implied.

Two Notes, Same Patient

The clearest way to see what the 2021 rules reward is one encounter documented two ways. Both notes below describe the same patient on the same day: a 62-year-old returning with worsening knee osteoarthritis, started on a prescription anti-inflammatory. The first note is long and thorough in the old style. The second is short and centered on the decision-making. Under today's rules, the second earns more.

Note A. Exhaustive 99213 · 1.30 wRVU

HPI: 62-year-old returns with right knee pain, present for several years and gradually worsening. Medial, aching, about 6 out of 10. Worse with stairs and prolonged standing, better with rest and ice. No locking or giving way, no recent trauma. Partial relief with acetaminophen.

ROS: Constitutional, eyes, ear/nose/throat, cardiovascular, respiratory, gastrointestinal, genitourinary, musculoskeletal, skin, neurological, psychiatric, endocrine, hematologic, and allergic systems reviewed, negative except as noted above.

Exam: Well-appearing, no distress. Heart regular. Lungs clear. Abdomen soft. Right knee: no effusion, full range of motion, mild medial joint line tenderness, ligaments stable, no warmth. Left knee normal. Neurologic exam grossly intact.

Assessment: Knee pain.

Plan: Recommend NSAIDs and activity modification. Return as needed.

Note B. Decision-focused 99214 · 1.92 wRVU

HPI: 62-year-old with known right knee osteoarthritis, returning with a three-week flare. Now limiting walking to less than two blocks and interfering with work. Acetaminophen no longer controlling it.

Exam: Right knee with small effusion, medial joint line tenderness, crepitus with motion, stable. Antalgic gait.

Assessment: Osteoarthritis of the right knee with acute exacerbation, now limiting ambulation.

Plan: Personally reviewed today's weight-bearing radiographs, showing medial joint space narrowing without acute change. Started meloxicam 15 mg daily (prescription drug management), gastrointestinal precautions reviewed. Discussed activity modification, a future corticosteroid injection, and referral for surgical evaluation if symptoms progress. Follow up in six weeks.

Same patient, same visit, the same medication started. The first note is several times longer and supports 99213, worth 1.30 wRVU. The second is a few sentences and supports 99214, worth 1.92, a difference of 0.62 wRVU on a single visit. Across a panel of similar visits, that gap is the difference between fair payment and a steady, invisible loss. The history and examination in the first note are not wrong; they simply no longer move the level. What moves it is naming the complexity of the problem, the data you reviewed, and the risk of your plan. The second note does that in three lines.

The losing note is the longer one

Effort stopped being the currency in 2021; documented decision-making took its place. You are almost certainly already doing the work shown in the second note. The only question is whether your note says so. Two of three elements, the problem and the risk here, stated plainly, carry the level.

Independent Interpretation: A Point Most Clinicians Misunderstand

One data element is worth getting exactly right, because it is both valuable and commonly misapplied: independent interpretation of a test. You earn this credit only when you personally interpret a study that someone else ordered or performed, and that you are not separately billing for. The classic example: an MRI is ordered in the emergency department or by a primary care colleague, the radiologist formally interprets and bills for it, and then you, the treating surgeon, review the actual images yourself and document your own read. Because the order and the billed interpretation belong to other providers, your independent interpretation counts.

Two limits follow from this. You cannot claim independent-interpretation credit for a test you ordered and are interpreting yourself, nor for one you are billing separately. And ordering a test already includes reviewing it: you get the data credit on the day you order it, and you cannot claim a fresh point for reviewing that same result at the next visit. When you do take independent-interpretation credit, document who ordered the study, the date, and your own interpretation; a formal radiology-style report is not required, but your read must be recorded.

Prescription Drug Management and the Over-the-Counter Trap

In the risk column, managing a prescription medication supports moderate risk, which is what drives a level 4 visit (99214 or 99204). Management is broad: starting a new prescription, refilling one, increasing or decreasing a dose, discontinuing one, or continuing a medication with documented clinical reasoning all qualify. For most clinicians this is the single most common path to a properly coded level 4, because so many visits involve a prescription decision.

One trap deserves emphasis, because auditors look for it. Writing an over-the-counter medication on a prescription pad does not turn it into prescription drug management. An over-the-counter drug is, by definition, a non-prescription drug, and recommending one supports low risk (a level 3), not moderate. The one exception is when you prescribe a strength higher than what is available over the counter, which is then genuinely a prescription. Keep the distinction clean: a true prescription medication supports level 4; an over-the-counter recommendation supports level 3, even if you wrote it on a prescription.

A reminder on how the table works, so this is used correctly: risk is one of the three MDM elements, and a level 4 needs two of the three at the moderate level. In practice, a prescription decision paired with the problem being addressed usually gets you there, but the level rests on the combination, not on the prescription alone.

Sources and Further Reading for This Chapter

American Medical Association, Evaluation and Management (E/M) Coding. https://www.ama-assn.org/practice-management/cpt/evaluation-and-management-em-coding
CMS, Physician Fee Schedule. https://www.cms.gov/medicare/payment/fee-schedules/physician

Previous Guide Guide 3: The 2021 E/M Revolution Next Guide Guide 5: Choosing Your Level of Service